The temporal evolution of acute respiratory distress syndrome following shock

European Journal of Anaesthesiology

Volumn 27, Issue 3, 2010, Pages 226-232

  Greer, Ruari ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute respiratory distress syndrome; Cytokines; Haemorrhage; Neutrophils; Pulmonary hypertension; Sepsis

Indexed keywords

ADRENALIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTOXIN; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDE; NEUROHORMONE; NITRIC OXIDE; NORADRENALIN; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASOPRESSIN;

ADULT RESPIRATORY DISTRESS SYNDROME; BLEEDING; CYTOKINE RELEASE; ENDOTHELIUM CELL; EVOLUTION; FIBROBLAST; FLUID RETENTION; HORMONE RELEASE; HUMAN; HYPOVOLEMIA; HYPOXIA; IMMUNE RESPONSE; INFLAMMATION; KIDNEY TUBULE ABSORPTION; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS; LUNG DISEASE; LUNG ENDOTHELIUM; LUNG HEMODYNAMICS; LUNG SEQUESTRATION; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SHOCK; SMOOTH MUSCLE FIBER; SYSTEMIC DISEASE; TISSUE INJURY; VASCULAR RESISTANCE; VASOMOTOR REFLEX;

ANIMALS; HEMORRHAGE; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOCK; SHOCK, SEPTIC; TIME FACTORS;

EID: 77953799475     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e3283308e7f     Document Type: Review

References (70)

1. Rinaldo JE, Christman JW. Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med 1990; 11:621-623.
2. Pepe PE, Potkin RT, Reus DH, et al. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982; 144:124-129.
3. Wilson W. State of men severely wounded in battle. Lancet 1944; 1:587-591
4. Brewer LA, Burbank B, Samson PC, et al. The 'Wet Lung' in War casualties. Ann Surg 1946; 343-362.
5. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2:319-323.
6. Bernard G, Artigas A, Brigham K, et al. The American-European Concensus Conference on ARDS: Definitions, Mechanisms, Relevant Outcomes and Clinical Trials Coordination. Am J Respr Crit Care Med 1994; 149:818-824.
7. Role of Inflammatory mediators in the pathophysiology of acute respiratory syndrome. Jl of Path 2004; 202:145-156.
8. Chapter 24 Pages 254-258 Textbook of Medical Physiology. Guyton and Hall Tenth Ed.
9. Sheeran P, Hall GM. Cytokines in anaesthesia. Br J Anaes 1997; 78:201-219.
10. Ferguson K, Taheri P, Rodriguez J, et al. Tumor necrosis factor activity increases in the early response to trauma. Acc Em Med 1997; 4:1035-1040.
11. Ayala A, Perrin MM, Meldrum DR, et al. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 1990; 2:170-174.
12. Ayala A, Wang P, Ba ZF, Perrin MM, et al. Differential alterations in plasma IL-6 and TNF levels after trauma and haemorrhage. Am J Phys 1991; 260:R167-R171.
13. Cruickshank AM, Fraser WD, Burns HJG, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying intensity. Clin Sci 1990; 79:161-165.
14. Joris J, Cigarini I, Legrand M, et al. Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Brit J Anaes 1992; 69:341-345.
15. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-891.
16. Remick DG, Kunkel GR, Lark JAW, et al. Acute in vivo effects of human recombinant tumour necrosis factor. Lab Invest 1987; 56:583-590.
17. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant cachectin. Science 1986; 234:470-474.
18. Tracey KJ, Fong y, Hesse DG, et al. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteriaemia. Nature 1987; 662-664.
19. Beutler BA, Milsark IW, Cerami A. Passive immunisation against cachectin/ tumour necrosis factor (TNF) protects mice against lethal effect of endotoxin. Science 1985; 229:869-871.
20. van Deventer SJH, Buller HR, Cate JWT, et al. Experimental endotoxiaemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990; 76:2520-2526.
21. Creasy AA, Stevens P, Kenney J, et al. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherechia coli. Circ Shock 1991; 33:84-91.
22. Michie HR, Spriggs DR, Manogue KR, et al. Tumour necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988; 104:280-286.
23. Leeper-Woodford SK, Carey PD, Byrne K, et al. Tumour necrosis factor: alpha and beta subtypes appear in the circulation during the onset of sepsis-induced lung injury. Am Rev Resp Dis 1991; 143:1076-1082.
24. Claude C, Boisson C, Harcun M, Thomachot L. Patterns of cytokine evolution (tumour necrosis factor-alpha and interleukin -6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997; 25:1813-1819.
25. Aird WD. Endothelial cell dynamics and complexity theory. Crit Care Med 2002; 30:S180-S185.
26. Minamatani H, Tsukada K, Sekizuka E, et al. Optical bioimaging: from living tissue to a single molecule: imaging and functional analysis of blood flow in the organic circulation. J Pharm Sc 2003; 93:227-233.
27. Schmidt H, Ebeling D, Bauer H, et al. Ketamine attenuates endotoxininduced leukocyte adherence in rat mesenteric venules. Crit Care Med 1995; 23:2008-2014.
28. Schmidt H, Ebeling D, Bauer H, et al. Influence of Platelet-Activating Factor Receptor Antagonist BN52021 on Endotoxin -Induced Leucocyte Adherence in Rat Mesenteric Venules. J Surg Res 1996; 60:29-35.
29. Jones DA, Abassi O, MacIntyre LV, et al. P-selectin mediates neutrophil rolling on histamine stimulated endothelial cells. Biophys J 1993; 65:1560-1569.
30. Abbassi O, Kishimoto TK, McIntire LV, et al. E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest 1993; 92:2719-2730.
31. Cummings CJ, Sessler L, Beall D, et al. Soluble E-Selectin Levels in Sepsis and Critical Illness. Am J Resp Crit Care Med 1997; 156:431-437.
32. Carlos TM, Harlan JM. Leucocyte endothelial adhesion molecules. Blood 1994; 84:2068-2101.
33. Traffic signals for lymphocyte recirculation and leucocyte emigration: the multistep paradigm Cell 1994; 76:301-314.
34. Leucocyte-endothelial interactions: clinical trials of antiadhesion therapy. Crit care med 2002; 5: S214-S219.
35. Malmros C, Holst E, Hansson L, Martensson L. Dynamic accumulation of neutrophils in lings and visceral organs during early abdominal sepsis in the pig. World J Surg 1994; 18:811-817.
36. Haslett C, Worthen GS, Giclas PC, et al. The pulmonary vascular sequestration of neutrophils n endotoxiaemia is initiated by an effect of endotoxin on the neutrophil in the rabbit. Am Rev Resp Dis 1987; 136:9-18.
37. Heirholzer C, Harbrecht B, Menzes JM, et al. Essential role of induced nitric oxide in the initiation of the inflammatory response to haemorrhage. J Exp Med 1998; 187:917-928.
38. Abraham E, Bursten S, Shenkar R, et al. Phosphatidic acid signalling mediates lung cytokine expression and lung inflammatory injury following haemorrhage. J Exp Med 1995; 181:569-575.
39. Terada LS, Dornish JJ, Shanley PF, et al. Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia reperfusion. Am J Physiol 1992; 263:L394-L401.
40. Nill M, Oberyszyn TM, Ross MS, et al. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin sensitive and C3H/HeJ endotoxin resistant mice. J Leukoc Biol 1995; 58:563-574.
41. Botha AJ, Moore FA, Moore EE, Kim FJ, et al. Post injury neutrophil priming and activation: an early vulnerable window. Surgery 1995; 118:358-365.
42. Wallther A, Weihrauch M, Schmidt W, et al. Leucocyte-independent plasma extravasasation during endotoxiaemia. Crit Care Med 2000; 28:2943-2948.
43. Moraes TJ, Chow CJ, Downey GP. Proteases and Lung Injury. Crit Care Med 2003; 31 (4 Suppl):S189-S194.
44. Pallister I, Dent C, Topley N. Increased neutrophil migratory activity after major trauma: a factor in the aetiology of acute respiratory distress syndrome? Crit Care Med 2002; 30:1717-1721.
45. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 13:643-647.
46. Bloomfield GL, Holloway S, Ridings PC, et al. Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med 1997; 25:563-565.
47. Lum H, Roebuck KA. Oxidant Stress and Endothelial Cell Dysfunction. Am J Physiol Cell Physiol 2001; 280:C719-C741.
48. Modelska K, Matthay MA, Brown LAS, et al. Inhibition of beta adrenergic - dependant alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock. Am J Physiol LungCell Mol Physiol 1999; 276:L844-L857.
49. Wilson JN, Pierce JD, Claney RL. Reactive oxygen species in acute respiratory distress syndrome. Heart Lung 2001; 30:370-375.
50. Bernard GR, Lucht WD, Niedermeyer ME, et al. Effect of N-acetyl cysteine on the pulmonary response to endotoxin in the wake sheep and upon in vitro granulocyte function. J Clin Invest 1984; 73:1772-1784.
51. Idell S, Kurich U, Fein A, et al. Neutrophil elastase releasing factorsin bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Resp Dis 1985; 132:1098-1105.
52. Donnelly SC, MacGregor I, Zamani A, et al. Plasma elastase levels and the development of adult respiratory distress syndrome. Am J Resp Crit Care Med 1995; 151:1428-1433.
53. Nirmalan M, Willard T, Edwards DJ, et al. Effects of sustained posttraumatic shock and initial fluid resuscitation on extravascular lung water content and pulmonary vascular pressures in a porcine model of shock. Br J Anaesth 2003; 91:224-232.
54. Chiara O, Pelosi P, Segala M, et al. Mesenteric and renal oxygen transport during haemorrhage and reperfusion: evaluation of optimal goals for treatment. J Trauma Inj Infect Crit Care 2001; 51:356-362.
55. Sori AJ, Rush BF, Lysz TW, et al. The gut as a source of sepsis after haemorrhagic shock. Am J Surg 1988; 155:187-192.
56. Kreil EA, Greene E, Ftzgibbon C, et al. The effect of human recombinant human tumour necrosis factor alpha, lymphotoxin, and Escherechia coli lipopoloysaccharide on haemodynamics, lung microvascular permeability and eiconasoid synthesis in anaesthetised sheep. Circ Res 1989; 65:502-504.
57. Pilati CF, Maron MB. Pulmonary haemodynamics and lung water content during splanchnic ischaemic shock. J Appl Physiol 1985; 58:1577-1584.
58. Kafi SA, Scillia P, Melot C, et al. Abnormal pulmonary vascular tone in canine oleic acid lung injury. Crit Care Med 2002; 30:1565-1569.
59. Koksoy C, Kuzu MA, Ergun H, et al. Intestinal ischaemia and reperfusion impairs vasomotor functions of the pulmonary vascular bed. Ann Surg 2000; 231:105-111.
60. Bloomfield GL, Holloway S, Ridings PC, et al. Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med 1997; 25:563-565.
61. Krell EA, Greene E, Robinson DR, et al. Effects of recombinanat human tumour necrosis factor alpha, lymphotoxin on hemodynamics, lung microvascular permeability and eiconasoid synthesis in anaesthetised sheep. Circ Res 1989; 65:502-514.
62. Worrall NK, Chang K, Le Jeune WS, et al. TNF -alpha causes reversible in vivo systemic vascular barier dysfunction via NO-dependant and independent mechanisms. Am J Physiol Heart Circ Physiol; 272: 2565-2574.
63. Rivkind AI, Siegel JH, Littleton M, et al. Neutrophil oxidative burst activation and pattern of respiratory physiological abnormalities in fulminant post traumatic adult respiratory distress syndrome. Circ Shock 1991; 33:48-62.
64. Meade P, Shoemaker WC, Donnelly TJ, et al. Temporal patterns of hemodynamics, oxygen transport, cytokine activityand complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma; 36:651-657.
65. Clermont G. Modelling longitudinal data in acute illness. Critical Care 2007; 11:152-153.
66. Marshall RP, Webb S, et al. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 2002; 121:68S-69S.
67. Cobb JP, O'Keefe GE. Injury research in the genomic era. The Lancet 2004; 363:2076-2083.
68. Leikauf GD, McDowell SA, Wesselkamper SC, et al. Acute lung injury: functional genomics and genetic susceptibility. Chest 2002; 121:70S- 75S.
69. Marshall JC, Vincent JL, Fink MP, et al. Measures, markers and mediators: toward a staging system for clinical sepsis. Areport of the Fofth Toronto Sepsis Roundtable, Toronto, Ontario Canada October 25-26, 2000. Crit Care Med 2003; 311560-311567.
70. Goldstein B, Faeder JR, Hlavacek WS. Mathematical and computational models of immune receptor signalling. Nat Rev Immunol 2002; 4:445-456.